Interface Biologics

Interface Biologics

Interface Biologics

Develops transformative biomedical polymer technology to improve safety of med device. Focused on anti-thrombogenic additives and combo drug delivery devices.
Founded
2001
Raised
$32M
Follow us
Alexa global traffic share